Vaccine-maker Pfizer said Monday that it would invest $120 million at its facility in Michigan, boosting U.S.-based production of the PAXLOVID coronavirus pill.
Pfizer announced its new oral Covid-19 treatment, Paxlovid, will be made in Portage, and it will be investing $120 Million dollars and creating some 250 jobs.
Pfizer to expand Paxlovid manufacturing in US to meet global demand pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir [PF-07321332] tablets and .